Navigation Links
Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President
Date:9/28/2010

SOUTH PLAINFIELD, N.J., Sept. 28 /PRNewswire/ -- Prolong Pharmaceuticals today announced that industry veteran Glenn Kazo has assumed the title of President. Mr. Kazo has been consulting in various capacities with Prolong since 2007. He succeeds Prolong founder Dr. Abraham Abuchowski, who remains Chief Executive Officer.

"I have known Glenn for more than thirty years," said Dr. Abuchowski, who co-founded Enzon Pharmaceuticals in 1981 with Mr. Kazo. "I feel he is one of the greatest strategic minds in the biopharmaceutical world today, with a long history of successful experience behind him guiding small companies and startups. Through his consulting input and counsel, Glenn has already played a central role in Prolong's development, and as we move into the next phase of product development he will assume the major operational responsibilities for the company," said Dr. Abuchowski.

At Enzon, Kazo headed the steering committee for the blockbuster cancer drug PEG-Interferon. As Vice President of Sales and Marketing he built and managed a significant business development and licensing group and launched the company's first two drugs, Adagen® and Oncaspar® . Following Enzon, Kazo joined Focal, Inc., now a division of Genzyme, and helped take that company public. He later served as US General Manager and a member of the Board of Directors for the UK-listed public company XTL Biopharmaceuticals, and subsequently as Chief Business Office for Activbiotics a private VC backed anti-infective company.  Kazo has been responsible for raising over $300M in capital from international investors, including a leading role in three successful IPOs.

About Prolong Pharmaceuticals

Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing biopharmaceutical products targeting the treatment of anemia resulting from an oxygen deficiency. First founded in 2002 as a research company Prolong is focused on
'/>"/>

SOURCE Prolong Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Updated Results from Phase 2 Trial Demonstrate Prolonged Hematologic Relapse-Free Survival of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
2. Trauma 411: Prolonged Surgery Should be Avoided in Certain Cases
3. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
4. Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
5. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
6. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
7. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
8. Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. Treating Depression Prolongs Life for Older People with Diabetes
11. Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control & Sexual Function in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Norgine B.V. today ... low volume bowel preparation, NER1006, presented at the 79 ... of Gastroenterology (ACG), Philadelphia, PA , ... weight and co-primary endpoint of cleansing success. The study ... MOVIPREP ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... CTI BioPharma Corp. (CTI) (NASDAQ and MTA: ... quarter 2014 financial results on Wednesday, October 29, 2014, ... the announcement, members of the management team will host ... provide a general corporate update at 4:30 p.m. EDT ... obtained as follows: Wednesday, October 29 ...
(Date:10/18/2014)... -- In a policy paper released today, ... lesbian, gay, bisexual and transgender (LGBT) civil rights ... Pre-Exposure Prophylaxis (PrEP). PrEP is any medical or ... of a disease or infection prior to exposure. ... combination currently approved for PrEP, which protects against ...
Breaking Medicine Technology:Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3
... 23, 2012  (OTC: IFIX) Internal Fixation Systems today announced ... to market subtalar implants. These implants are used to ... both trauma conditions and arthritis.  IFS CEO, Stephen Dresnick, ... to fill out our portfolio, and gives us another ...
... Dana Taschner from the Los Angeles office of ... California,s best lawyers in the annual Southern California Super Lawyers ... Taschner has earned the Super Lawyers distinction. He holds ... The Best Lawyers in America , one of the leading guides ...
Cached Medicine Technology:Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants 2The Lanier Law Firm's Dana Taschner Recognized Among Southern California's Top Lawyers 2
(Date:10/20/2014)... Columbus, OH (PRWEB) October 20, 2014 ... joined Specialists in Obstetrics & Gynecology of Columbus, Inc., ... specialized women’s healthcare services to more than 100,000 patients ... care though all ages and stages of a women’s ... office locations in Westerville and Dublin. , ...
(Date:10/20/2014)... October 20, 2014 JZ Fitness, an ... coaching, corporate wellness programming, authorship, international lecturing and community ... to announce the release of the JZ Fitness nutrition ... years of coaching thousands of individuals on nutrition, Jenn ... that does not require calorie counting or cumbersome food ...
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 ... Matthew Voicheck as Assistant Director of their ... role in managing the innovative turnkey drug sourcing, ... , Matthew brings over 12 years of industry ... joins Myoderm at the peak of their international ...
(Date:10/20/2014)... 2014 National Teen Driver Safety Week is ... Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is joining ... of teen drivers to talk to their teens and always ... vehicle crashes are the leading cause of death for U.S. ... fatal crashes, and 859 (42%) of those teen drivers were ...
(Date:10/20/2014)... October 20, 2014 Punzoné , the ... the U.S., has a lot to celebrate this month. October ... recognizes the achievements and contributions of Americans of Italian heritage ... Punzoné, and today it shares its favorite Italian cocktails and ... to Italy - even if it is only in a ...
Breaking Medicine News(10 mins):Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4
... WINSTON-SALEM, N.C. May 1, 2012 With nearly one-third ... there is an acute need for more effective treatments. In ... high as 73 percent, and even in successful programs, the ... obesity are considered the gold standard of treatment, theories of ...
... education process may provide an antidote to the emotional ... and after an operation, according to a new study ... of the American College of Surgeons. Specifically, ... 30-minute preparation video reported less anxiety about the procedure, ...
... alcohol advertising and marketing is a missed opportunity for ... review of state alcohol advertising laws from the Center ... Hopkins Bloomberg School of Public Health. The ... laws incorporate eight different best practices to reduce youth ...
... Clarksburg, MDThis week, the second-year results of an important ... the Comparison of AMD Treatments Trials (or CATT), were ... found that two drugs known as Avastin (bevacizumab) and ... of AMD, were similarly effective in maintaining vision. ...
... -- A management plan to gather, assess and respond to ... approved until they are no longer on the market is ... an Institute of Medicine report released Tuesday. The U.S. ... trial evidence that their benefits outweigh their risks. However, the ...
... By Kathleen Doheny HealthDay Reporter , MONDAY, April ... help women in their 40s interpret mammogram guidelines says those ... breast tissue should start getting regular screenings. The ... risks for these particular women, who are at increased risk ...
Cached Medicine News:Health News:Treating childhood obesity: A family affair 2Health News:Study finds that patient education videos viewed before an operation may benefit patients 2Health News:Study finds that patient education videos viewed before an operation may benefit patients 3Health News:Majority of states fail to address youth exposure to alcohol marketing 2Health News:Interpreting the Avastin-Lucentis study for persons with macular degeneration 2Health News:Interpreting the Avastin-Lucentis study for persons with macular degeneration 3Health News:Better Ways Needed to Track Drug Safety: Report 2Health News:Better Ways Needed to Track Drug Safety: Report 3Health News:Here Are the Women Who Need Mammograms in Their 40s: Study 2Health News:Here Are the Women Who Need Mammograms in Their 40s: Study 3
... Pulse Oximeter with Oxismart XL Advanced Signal ... through nonspecific noise to find the pulse ... pulse rate values. , ,The N395 ... Management, a breakthrough in clinician-programmable alarm sensitivity ...
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery....
... After inserting a finger into ... turned on, and continuous measurement is ... 11mm character height. In darker surroundings, ... easy reading., ,Light weight, compact ...
Medicine Products: